153 related articles for article (PubMed ID: 11526720)
1. [Role of Ca 125 in pelvic masses. Our experience].
Rotondi M; Lauro C; Ammaturo FP; Guerriero V; Rasile M; Panariello S
Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):51-4. PubMed ID: 11526720
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter study.
Schutter EM; Kenemans P; Sohn C; Kristen P; Crombach G; Westermann R; Môbus V; Kaufmann M; Caffier H; Schmidt-Rhode P
Cancer; 1994 Aug; 74(4):1398-406. PubMed ID: 8055463
[TBL] [Abstract][Full Text] [Related]
3. Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study.
Schutter EM; Sohn C; Kristen P; Möbus V; Crombach G; Kaufmann M; Caffier H; Kreienberg R; Verstraeten AA; Kenemans P
Gynecol Oncol; 1998 Apr; 69(1):56-63. PubMed ID: 9570999
[TBL] [Abstract][Full Text] [Related]
4. Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.
Stirling D; Evans DG; Pichert G; Shenton A; Kirk EN; Rimmer S; Steel CM; Lawson S; Busby-Earle RM; Walker J; Lalloo FI; Eccles DM; Lucassen AM; Porteous ME
J Clin Oncol; 2005 Aug; 23(24):5588-96. PubMed ID: 16110018
[TBL] [Abstract][Full Text] [Related]
5. A proposal for a new scoring system to evaluate pelvic masses: Pelvic Masses Score (PMS).
Rossi A; Braghin C; Soldano F; Isola M; Capodicasa V; Londero AP; Forzano L; Marchesoni D
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):84-8. PubMed ID: 21440361
[TBL] [Abstract][Full Text] [Related]
6. Screening for ovarian cancer: a pilot randomised controlled trial.
Jacobs IJ; Skates SJ; MacDonald N; Menon U; Rosenthal AN; Davies AP; Woolas R; Jeyarajah AR; Sibley K; Lowe DG; Oram DH
Lancet; 1999 Apr; 353(9160):1207-10. PubMed ID: 10217079
[TBL] [Abstract][Full Text] [Related]
7. The role of transvaginal ultrasonography and serum CA 125 assay combined with age and hormonal state in the differential diagnosis of pelvic masses.
Mancuso A; De Vivo A; Triolo O; Irato S
Eur J Gynaecol Oncol; 2004; 25(2):207-10. PubMed ID: 15032283
[TBL] [Abstract][Full Text] [Related]
8. A combined approach for the early detection of ovarian cancer in asymptomatic women.
Adonakis GL; Paraskevaidis E; Tsiga S; Seferiadis K; Lolis DE
Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 65(2):221-5. PubMed ID: 8730628
[TBL] [Abstract][Full Text] [Related]
9. Is there any value in bimanual pelvic examination as a screening test.
Grover SR; Quinn MA
Med J Aust; 1995 Apr; 162(8):408-10. PubMed ID: 7746172
[TBL] [Abstract][Full Text] [Related]
10. Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses.
Yamamoto Y; Yamada R; Oguri H; Maeda N; Fukaya T
Eur J Obstet Gynecol Reprod Biol; 2009 Jun; 144(2):163-7. PubMed ID: 19327881
[TBL] [Abstract][Full Text] [Related]
11. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
12. Can manipulation of a pelvic tumour influence the serum level of cancer antigen 125 and cancer-associated serum antigen?
Kiekegaard O; Mogensen O; Mogensen B; Ahrons S
Br J Cancer; 1998 Jun; 77(11):2012-3. PubMed ID: 9667684
[TBL] [Abstract][Full Text] [Related]
13. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses.
Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H
Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of benign pelvic mass with high serum levels of CA(125)].
Zhang X; Wu LY; Li XJ; Li HJ; Zhang R; Liu LY
Zhonghua Fu Chan Ke Za Zhi; 2005 Mar; 40(3):178-82. PubMed ID: 15840313
[TBL] [Abstract][Full Text] [Related]
15. Population screening and early detection of ovarian cancer in asymptomatic women.
Nelson AE; Francis JE; Zorbas H;
Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):448-50. PubMed ID: 19780723
[TBL] [Abstract][Full Text] [Related]
16. Advances in the early detection of ovarian carcinoma.
Garner EI
J Reprod Med; 2005 Jun; 50(6):447-53. PubMed ID: 16050569
[TBL] [Abstract][Full Text] [Related]
17. [Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].
Cnota W; Sodowski K; Olesiak-Andryszczak M; Pilch-Kowalczyk M
Wiad Lek; 2004; 57 Suppl 1():43-7. PubMed ID: 15884203
[TBL] [Abstract][Full Text] [Related]
18. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer.
Olivier RI; Lubsen-Brandsma MA; Verhoef S; van Beurden M
Gynecol Oncol; 2006 Jan; 100(1):20-6. PubMed ID: 16188302
[TBL] [Abstract][Full Text] [Related]
19. Imaging and Screening of Ovarian Cancer.
Lowry KP; Lee SI
Radiol Clin North Am; 2017 Nov; 55(6):1251-1259. PubMed ID: 28991564
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer early detection program.
Farley KM
Oncol Nurs Forum; 1999 Jun; 26(5):833-4. PubMed ID: 10382179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
